Orthostatic Hypotension and Orthostatic Intolerance

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 2, Issue , 2010, Pages 2063-2082

  Mathias, Christopher J ^a   Galizia, Gianluigi ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84655172534     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00113-1     Document Type: Chapter

References (126)

1. R Hainsworth (1985) Arterial blood pressure. GEH Henderby,(Eds) Hypotensive anaesthesia Edinburgh: Churchill Livingstone 3-29.
2. L Hill (1895) The influence of the force of gravity on the circulation of the blood. J Physiol (Lond) 18 15-53.
3. HB Lillywhite (1988) Snakes, blood circulation and gravity. Sci Am 259 92-98.
4. BG Wallin and L-E Linblad (1988) Baroreflex mechanisms controlling sympathetic outflow to the muscles. P Sleight,(Eds) Arterial baroreceptors and hypertension Oxford: Oxford University Press 101.
5. CJ Mathias (2003) Autonomic diseases—clinical features and laboratory evaluation. J Neurol Neurosurg Psychiatry 74 31-41.
6. CJ Mathias (2004) Disorders of the autonomic nervous system. WG Bradley, RB Daroff, GM Fenichel, et al., (Eds) Neurology in clinical practice ed 3 Boston: Butterworth-Heinemann 2403–2240
7. MW Bungo, DJ Goldwater, RL Popp, et al. (1985) Cardiovascular deconditioning during space flight and the use of saline as a countermeasure to orthostatic intolerance. Aviat Space Environ Med 56 985-990.
8. CJ Mathias, R Mallipeddi and K Bleasdale-Barr (1999) Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy. J Neurol 246 893-898.
9. CJ Mathias (2002) To stand on one's own legs. Clin Med 2 237-245.
10. CJ Mathias and H Frankel (2002) Autonomic disturbances in spinal cord lesions. CJ Mathias, R Bannister,(Eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system ed 4 Oxford: Oxford University Press 494-513.
11. K Bleasdale-Barr and CJ Mathias (1998) Neck and other muscle pains in autonomic failure: their association with orthostatic hypotension. J Roy Soc Med 91 355-359.
12. CJ Mathias, P Fosbraey, DF da Costa, et al. (1986) The effect of desmopressin on nocturnal polyuria, overnight weight loss and morning postural hypotension in patients with autonomic failure. Br Med J 293 353-354.
13. CJ Mathias (2000) A 21st century water cure. The Lancet 356 1046-1048.
14. CJ Mathias and R Bannister (2002) Postprandial hypotension in autonomic disorders. CJ Mathias, R Bannister,(Eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system ed 4 Oxford: Oxford University Press 283-295.
15. CJ Mathias, DF da Costa, P Fosbraey, et al. (1989) Cardiovascular, biochemical and hormonal changes during food induced hypotension in chronic autonomic failure. J Neurol Sci 94 255-269.
16. CJ Mathias, E Holly, E Armstrong, et al. (1991) The influence of food on postural hypotension in three groups with chronic autonomic failure: clinical and therapeutic implications. J Neurol Neurosurg Psychiatry 54 726-730.
17. GDP Smith, LP Watson, DV Pavitt, et al. (1995) Abnormal cardiovascular and catecholamine responses to supine exercise in human subjects with sympathetic dysfunction. J Physiol (London) 485 255-265.
18. GD Smith and CJ Mathias (1995) Postural hypotension enhanced by exercise in patients with chronic autonomic failure. QJM 88 251-256.
19. S Puvi-Rajasingham, GDP Smith, A Akinola, et al. (1997) Abnormal regional blood flow responses during and after exercise in human sympathetic denervation. J Physiol 505 481-489.
20. CJ Mathias, WB Matthews and JMK Spalding (1977) Postural changes in plasma renin activity and response to vasoactive drugs in a case of Shy-Drager syndrome. J Neurol Neurosurg Psychiatry 2 147-156.
21. CJ Mathias, K Deguchi and I Schatz (2001) Observations on recurrent syncope and presyncope in 641 patients. Lancet 357 348-353.
22. CJ Mathias and R Bannister (2002) Investigation of autonomic disorders. CJ Mathias, R Bannister,(Eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system ed 4 Oxford: Oxford University Press 169-195.
23. PA Low and E Benarroch (2008) Clinical autonomic disorders. ed 3 Philadelphia: Lippincott-Raven
24. WW Swingle, JP DaVanzo, HC Crossfield, et al. (1959) Glucocorticoids and maintenance of blood pressure and plasma volume of adrenalectomized dogs subjected to stress. Proc Soc Exp Biol Med 100 617-622.
25. RD Gordon, O Kuchel, GW Liddle, et al. (1967) Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J Clin Invest 46 599-605.
26. CJ Mathias, CN May and GM Taylor (1984) The renin-angiotensin system and hypertension—basic and clinical aspects. ADB Malcolm,(Eds) Molecular medicine vol 1 Oxford and Washington DC: IRL Press 177-208.
27. PG Schmid, JW Eckstein and FM Abboud (1966) Effect of 9-α-fluorohydrocortisone on forearm vascular responses to norepinephrine. Circulation 34 620-626.
28. PG Schmid, JW Eckstein and FM Abboud (1967) Effect of 9-α-fluorohydrocortisone on forearm venous responses to norepinephrine and tyramine. J Appl Physiol 23 571-574.
29. C Spach and DHP Streeten (1964) Retardation of sodium exchange in dog erythrocytes by physiological concentrations of aldosterone in vitro. J Clin Invest 43 217-227.
30. RH Smithwick, WER Greer, CW Robertson, et al. (1950) Pheochromocytoma: a discussion of symptoms, signs and procedures of diagnostic value. N Engl J Med 242 252-257.
31. DHP Streeten and GH Anderson Jr (1996) Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am J Hypertens 9 760-769.
32. G Leonetti, L Terzoli, G Bianchini, et al. (1981) Norepinephrine reactivity in patients with phaeochromocytoma before and after surgical correction. Clin Sci (Colch) 6(suppl 7), 211s-213s.
33. IB Davies, CJ Mathias, D Sudera, et al. (1982) Agonist regulation of alpha-adrenergic receptor responses in man. J Cardiovasc Pharmacol 4 s139-s144.
34. O-E Brodde and KD Bock (1984) Changes in platelet alpha2-adrenergic receptors in human phaeochromocytoma. Eur J Clin Pharmacol 26 265-267.
35. JG McLeod (2002) Autonomic dysfunction in peripheral nerve disease. CJ Mathias, R Bannister,(Eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system ed 4 Oxford: Oxford University Press 367-377.
36. CJ Mathias (2002) Neurodegeneration, parkinsonian syndromes and autonomic failure. Auton Neurosci 96 50-58.
37. M Matthews (2002) Autonomic ganglia and preganglionic neurones in autonomic failure. CJ Mathias, R Bannister,(Eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system ed 4 Oxford: Oxford University Press 329-339.
38. CJ Mathias and AC Williams (1994) The Shy Drager syndrome (and multiple system atrophy). DB Calne,(Eds) Neurodegenerative Diseases ed 1 Philadelphia: WB Saunders Company 743-768.
39. GK Wenning, Y Ben Shlomo, M Magalhaes, et al. (1994) Clinical features and anatural history of multiple system atrophy: an analysis of 100 cases. Brain 117 835-845.
40. S Gilman, P Low, N Quinn, et al. (1998) Consensus statement on the diagnosis of multiple system atrophy. Clin Auton Res 8 359-362.
41. S Daniel (2002) The neuropathology and neurochemistry of multiple system atrophy. CJ Mathias, R Bannister,(Eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system ed 4 Oxford: Oxford University Press 321-328.
42. K Seppi (2007) MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice. Parkinsonism Relat Disord 13(suppl 3), S400-S405.
43. J Kimber, M Sivenandan, L Watson, et al. (2001) Age- and gender-related growth hormone responses to intravenous clonidine in healthy adults. Growth Horm IGF Res 11 128-135.
44. T Thomaides, KR Chaudhuri, S Maule, et al. (1992) The growth hormone response to clonidine in central and peripheral primary autonomic failure. Lancet 340 263-266.
45. JR Kimber, L Watson and CJ Mathias (1997) Distinction of idiopathic Parkinson's disease from multiple system atrophy by stimulation of growth hormone release with clonidine. Lancet 349 1877-1881.
46. JR Kimber and CJ Mathias (1999) Neuroendocrine responses to levodopa in multiple system atrophy (MSA). Mov Disord 14 981-987.
47. E Friess, T Kuempfel, J Winkelmann, et al. (2001) Increased growth hormone response to apomorphine in Parkinson disease compared with multiple system atrophy. Arch Neurol 5 241-246.
48. J-M Senard, S Rai, M Lapeyre-Mestre, et al. (1997) Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry 63 578-589.
49. CJ Mathias (1998) Cardiovascular autonomic dysfunction in parkinsonian patients. Clin Neurosci 5 153-166.
50. S Hakusui, T Yasuda, T Yanagi, et al. (1994) A radiological analysis of heart sympathetic functions with meta-[123I] iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 49 81-84.
51. S Orimo, E Ozawa, S Nakade, et al. (1999) 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 67 189-194.
52. F Courbon, C Brefel-Courbon, C Thalamas, et al. (2003) Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord 18 890-897.
53. DS Goldstein, C Holmes, RO Cannon III, et al. (1997) Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 336 696-702.
54. AJ Larner, CJ Mathias and MN Rossor (2000) Autonomic failure preceding dementia with Lewy bodies. J Neurol 247 229-231.
55. Y Horimoto, M Matsumoto, H Akatsu, et al. (2003) Autonomic dysfunction in dementia with Lewy bodies. J Neurol 250 530-533.
56. H Oka, M Morita, K Onouchi, et al. (2007) Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson's disease. J Neurol Sci 254 72-77.
57. J Kimber, CJ Mathias, AJ Lees, et al. (2000) Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy. Brain 123 1422-1430.
58. P Anand, P Rudge, CJ Mathias, et al. (1991) New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides. Lancet 337 1253-1254.
59. FB Axelrod (1999) Familial dysautonomia. CJ Mathias, R Bannister,(Eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system ed 4 Oxford: Oxford University Press 402-409.
60. MM Reilly and PK Thomas (1999) Amyloid polyneuropathy. CJ Mathias, R Bannister,(Eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system ed 4 Oxford: Oxford University Press 410-420.
61. CJ Mathias and R Bannister (2002) Dopamine beta-hydroxylase deficiency and other genetically determined autonomic disorders. R Bannister, CJ Mathias,(Eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system ed 3 Oxford: Oxford University Press 387-401.
62. CJ Mathias, R Bannister, P Cortelli, et al. (1990) Clinical autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to an inability to synthesize norepinephrine from dopamine because of a deficiency of dopamine beta-hydroxylase. QJM 278 617-633.
63. PJ Watkins (1998) The enigma of autonomic failure in diabetes. J R Coll Physicians Lond 32 360-365.
64. DA Greene, SA Lattimer and AAF Sima (1988) Are disturbances of sorbitol, phosphoinositide, and Na+-K+ ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes 37 688-693.
65. DJ Ewing, IW Campbell, AA Burt, et al. (1973) Vascular reflexes in diabetic autonomic neuropathy. Lancet 2 1354-1356.
66. PJ Watkins and ME Edmonds (2002) Diabetic autonomic failure. CJ Mathias, R Bannister,(Eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system ed 4 Oxford: Oxford University Press 378-386.
67. G Sundkvist, S Bornmyr, H Svensson, et al. (1998) Sympathetic neuropathy is more frequent than parasympathetic neuropathy in patients with a short duration of type 2 diabetes. Clin Auton Res 8 281.
68. PE Cryer, AB Silverberg, JV Santiago, et al. (1978) Plasma catecholamines in diabetes. Am J Med 64 407-416.
69. RD Hoeldtke and DHP Streeten (1993) Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 329 611-615.
70. AR Christlieb and JJ Bratten (1974) Decreased response of plasma renin activity to orthostasis in diabetic patients with orthostatic hypotension. Diabetes 23 835-840.
71. CJ Mathias, NJ Christensen, JL Corbett, et al. (1975) Plasma catecholamines, plasma renin activity and plasma aldosterone in tetraplegic man, horizontal and tilted. Clin Sci Mol Med 49 291-299.
72. CJ Mathias, NJ Christensen, JL Corbett, et al. (1976) Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man. Circ Res 39 204-208.
73. CJ Mathias, NJ Christensen, HL Frankel, et al. (1979) Cardiovascular control in recently injured tetraplegics in spinal shock. QJM 48 273-287.
74. CJ Mathias, K Deguchi, K Bleasdale-Barr, et al. (1998) Frequency of family history in vasovagal syncope. Lancet 352 33-34.
75. W Wieling and JJ Van Lieshout (1997) Maintenance of postural normotension in humans. PA Low,(Eds) Clinical autonomic disorders ed 2 Boston: Little Brown & Co 73-82.
76. KM El Badawi and R Hainsworth (1994) Combined head-up tilt and lower body suction: a test of orthostatic intolerance. Clin Auton Res 4 41-47.
77. SJ McIntosh, J Lawson and RA Kenny (1993) Clinical characteristics of vasodepressor, cardioinhibitory and mixed carotid sinus syndrome in the elderly. Am J Med 95 203-208.
78. M Brignole, P Alboni, DG Benditt, et al. (2004) Guidelines on management (diagnosis and treatment) of syncope—update 2004. Task force on syncope, European Society of Cardiology. Europace 6 467-537.
79. AM Humm and CJ Mathias (2006) Unexplained syncope—is screening for carotid sinus hypersensitivity indicated in all patients aged >40 years? Neurol Neurosurg Psychiatry 77 1267-1270.
80. CJ Mathias (2000) Autonomic dysfunction. J Grimley-Evans,(Eds) Oxford textbook of geriatric medicine ed 2 Oxford: Oxford University Press 833-852.
81. CJ Mathias, E Armstrong, N Browse, et al. (1991) Value of non-invasive continuous blood pressure monitoring in the detection of carotid sinus hypersensitivity. Clin Auton Res 2 157-159.
82. W Wieling, CT Krediet, N van Dijk, et al. (2007) Initial orthostatic hypotension: review of a forgotten condition. Clin Sci (Lond) 112 157-165.
83. PA Low, R Schondorf and TA Rummans (2001) Why do patients have orthostatic symptoms in PoTS? Clin Auton Res 11 223-224.
84. G Jacob, F Costa, JR Shannon, et al. (2000) The neuropathic postural tachycardia syndrome. N Engl J Med 343 1008-1014.
85. S Vernino, PA Low, RD Fealey, et al. (2000) Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343 847-855.
86. JR Shannon, NL Flatten, J Jordan, et al. (2000) Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342 541-549.
87. PA Low, P Sandroni, M Joyner, et al. (2009) Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol 20 352-358.
88. EM Garland, SR Raj, BK Black, et al. (2007) The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology 69 790-798.
89. J Jordan, JR Shannon, A Diedrich, et al. (2002) Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity. Hypertension 39 173-178.
90. M Thieben, P Sandroni, D Sletten, et al. (2007) Postural orthostatic tachycardia syndrome—Mayo Clinic experience. Mayo Clin Proc 82 308-313.
91. S Masuki, JH Eisenach, CP Johnson, et al. (2007) Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety. J Appl Physiol 102 896-903.
92. BP Grubb (2008) Postural tachycardia syndrome. Circulation 117 2814-2817.
93. Y Gazit, AM Nahir, R Grahame, et al. (2003) Dysautonomia in the joint hypermobility syndrome. Am J Med 115 33-40.
94. H Tanaka, Y Fujita, Y Takenaka, et al. (2009) Task force of clinical guidelines for child orthostatic dysregulation, Japanese Society of Psychosomatic Pediatrics. Japanese clinical guidelines for juvenile orthostatic dysregulation version 1. Pediatr Int 51 169-179.
95. I Nozawa, S Imamura, K Hashimoto, et al. (1998) Psychosomatic aspects of patients complaining of dizziness or vertigo with orthostatic dysregulation. Auris Nasus Larynx 25 33-38.
96. PA Low (2008) Prevalence of orthostatic hypotension. Clin Auton Res 18(suppl 1), 8-13.
97. V Gupta and LA Lipsitz (2007) Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med 120 841-847.
98. GC Verwoert, FU Mattace-Raso, A Hofman, et al. (2008) Orthostatic hypotension and risk of cardiovascular disease in elderly people: the Rotterdam study. J Am Geriatr Soc 56 1816-1820.
99. KP Davy, DR Seals and H Tanaka (1998) Augmented cardiopulmonary and integrative sympathetic baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension 32 298-304.
100. EG Lakatta (2002) Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Failure Rev 7 29-49.
101. GH Rutan, B Hermanson, DE Bild, et al. (1992) Orthostatic hypotension in older adults. The Cardiovascular Health Study. Hypertension 19 508-519.
102. HC Heims, HD Critchley, NH Martin, et al. (2006) Cognitive functioning in orthostatic hypotension due to pure autonomic failure. Clin Auton Res 16 113-120.
103. T Harris, LA Lipsitz, JC Kleinman, et al. (1991) Postural change in blood pressure associated with age and systolic blood pressure. The National Health and Nutrition Examination Survey II. J Gerontol 46 M159-M163.
104. I Hajjar (2005) Postural blood pressure changes and orthostatic hypotension in the elderly patient: impact of antihypertensive medications. Drugs Aging 22 55-68.
105. CJ Mathias (2003) Autonomic diseases: management. J Neurol Neurosurg Psychiatry 74 iii42-iii47.
106. CJ Mathias and TM Young (2003) Plugging the leak—the benefits of the vasopressin-2 agonist, desmopressin in autonomic failure. Clin Auton Res 13 85-87.
107. W Wieling, JJ van Lieshout and AM van Leeuwen (1993) Physical manoeuvres that reduce postural hypotension. Clin Auton Res 3 57-65.
108. AAJ Smit, MA Hardjowijono and W Wieling (1997) Are portable folding chairs useful to combat orthostatic hypotension? Ann Neurol 42 975-978.
109. P Cariga and CJ Mathias (2001) The haemodynamics of the pressor effect of oral water in human sympathetic denervation due to autonomic failure. Clin Sci 101 313-319.
110. CJ Mathias and TM Young (2004) Water drinking in the management of orthostatic intolerance due to orthostatic hypotension, vasovagal syncope and the postural tachycardia syndrome. Eur J Neurol 11 613-619.
111. DS Goldstein (2006) L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug. Cardiovasc Drug Rev 24 189-203.
112. CJ Mathias, J Senard, S Braune, et al. (2001) L-threo-dihydroxphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-centre, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 11 235-242.
113. CJ Mathias (2008) L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience. Clin Auton Res 18(suppl 1), 25-29.
114. R Sakakibara, S Matsuda, T Uchiyama, et al. (1993) The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res 13 106-108.
115. PA Low, JL Gilden, R Freeman, et al. (1997) Efficacy of midodrine vs. placebo in neurogenic orthostatic hypotension: a randomized, double-blind multicenter study. JAMA 277 1046-1051.
116. W Singer, P Sandroni and TL Opfer-Gehrking (2006) Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 63 513-518.
117. O Oldenburg, AN Mitchell, J Nurnberger, et al. (2001) Ambulatory norepinephrine treatment of severe autonomic orthostatic hypotension. J Am Coll Cardiol 37 219-223.
118. J Kimber, L Watson and CJ Mathias (2001) Cardiovascular and neurohormonal responses to i.v. l-arginine in two groups with primary autonomic failure. J Neurol 248 1036-1041.
119. R Freeman, J Young, L Landsbert, et al. (1996) The treatment of postprandial hypotension in autonomic failure with 3,4-DL-threo-dihydroxphenylserine. Neurology 47 1414-1420.
120. GDP Smith, M Alam, LP Watson, et al. (1995) Effects of the somatostatin analogue, octreotide, on exercise induced hypotension in human subjects with chronic sympathetic failure. Clin Sci 89 367-373.
121. M Alam, GDP Smith, K Bleasdale-Barr, et al. (1995) Effects of the peptide release inhibitor, Octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure. J Hypertens 13 1664-1669.
122. ZJ Jian and BY Zhou (2008) Efficacy and safety of acarbose in the treatment of elderly patients with postprandial hypotension. Chin Med J (Engl) 121 2054-2059.
123. VL Cooper and R Hainsworth (2002) Effects of dietary salt on orthostatic tolerance, blood pressure and baroreceptor sensitivity in patients with syncope. Clin Auton Res 12 234-241.
124. DG Benditt (1999) Cardiac pacing for prevention of vasovagal syncope. J Am Coll Cardiol 33 21-23.
125. M Brignole, F Croci, C Menozzi, et al. (2004) Isometric arm contraction at the onset of prodromal symptoms: a new first-line treatment for vasovagal syncope. A Raviele,(Eds) Cardiac arrhythmias Milan: Springer 641-650.
126. N van Dijk, MP Harms, M Linzer, et al. (2000) Treatment of vasovagal syncope: pacemaker or crossing legs? Clin Auton Res 10 347-349.